mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

3.0 T multiparametric prostate MRI using pelvic phased-array coil: Utility for tumor detection prior to biopsy

Rosenkrantz AB et al. – Magnetic resonance imaging had weaker specificity for prediction of a subsequent positive biopsy, as well as weaker sensitivity for tumor on a per–lobe basis, indicating that in patients with a positive MRI result, tissue sampling remains necessary for confirmation of the diagnosis as well as for treatment planning.

Methods
  • Forty-two patients without biopsy-proven cancer and who underwent MRI were included.
  • In all patients, MRI was performed at 3T using a pelvic phased-array coil and included T2-weighted imaging, diffusion-weighted imaging, and dynamic contrast-enhanced imaging.
  • Thirteen had undergone no previous biopsy, and 29 had undergone at least 1 previous negative biopsy.
  • All patients underwent prostate biopsy following MRI.
  • Two fellowship-trained radiologists in consensus reviewed all cases and categorized each lobe as positive or negative for tumor.
  • These interpretations were correlated with findings on post-MRI biopsy.

Results
  • Follow-up biopsy was positive in 23 lobes in 15 patients (36% of study cohort).
  • On a per-patient basis, MRI had a sensitivity of 100%, specificity of 74%, positive predictive value (PPV) of 68%, and negative predictive value (NPV) of 100%.
  • On a per-lobe basis, MRI had a sensitivity of 65%, specificity of 84%, PPV of 60%, and NPV of 86%.
  • There was a nearly significant association between Gleason score and tumor detection on MRI (P = 0.072).
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close